Papa Medical Inc. (PAPA)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	95.00M
Revenue	37.00M
Net Income	1.40M
EPS	0.06
Shares Out	23.75M
PE Ratio	68.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PAPA

Papa Medical is the first end-to-end innovative cannabis dosing solution provider in the US that possesses the medical atomization or nebulizing background and sells nebulizer, according to the Frost & Sullivan Report. We deeply engage in the key activities in the cannabis and consuming E-vapors industry, from the research and development, formulation design, e-liquid production, e-liquid filling to e-liquid co-packing services. We believe our full-cycle operations and leading market position will position us to further capitalize on the growth...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2018
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: PAPA

Data Source: SEC filings Last updated: Aug 20, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error